Otros idiomas Emergent BioSolutions Inc.

Acciones

EBS

US29089Q1058

Mercado cerrado - Nyse Otros sitios de cotización 22:00:02 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
1,92 ^USD	-1,54 %		-5,88 %	-20,00 %

24/04	La FDA autoriza a Amneal Pharmaceuticals a vender la versión genérica del aerosol nasal para tratar la sobredosis de opiáceos -- Suben las acciones	MT
25/03	Emergent obtiene de la FDA la clasificación de "acción no indicada" para su planta de fabricación de Baltimore Bayview	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Amneal Pharmaceuticals Cleared by FDA to Sell Generic Version of Nasal Spray to Treat Opioid Overdose -- Shares Rise	24/04
Emergent BioSolutions to Release First Quarter 2024 Financial Results and Conduct Conference Call on May 1, 2024	23/04
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024	22/04
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis	28/03
Emergent Gets FDA's 'No Action Indicated' Status For Baltimore Bayview Manufacturing Facility	25/03
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility	25/03
Emergent Biosolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility	25/03
Sector Update: Health Care Stocks Rise Late Afternoon	12/03
Sector Update: Health Care Stocks Higher in Afternoon Trading	12/03
Emergent BioSolutions Tumbles After S&P Global Credit Downgrade	12/03
Emergent BioSolutions Shares Drop on S&P Downgrade	12/03
North American Morning Briefing : Stock Futures -2-	08/03
News Highlights : Top Company News of the Day - Thursday at 1 AM ET	07/03
News Highlights : Top Company News of the Day - Wednesday at 11 PM ET	07/03
News Highlights : Top Company News of the Day - Wednesday at 9 PM ET	07/03
News Highlights : Top Company News of the Day - Wednesday at 7 PM ET	07/03
Emergent Biosolutions: Q4 Earnings Snapshot	06/03
(EBS) EMERGENT BIOSOLUTIONS Sees Q1 Revenue Range $200M - $250M	06/03
Earnings Flash (EBS) EMERGENT BIOSOLUTIONS Reports Q4 Revenue $277M, vs. Street Est of $274M	06/03
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results	06/03

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Emergent BioSolutions Inc.

Acciones

EBS

US29089Q1058

Otros idiomas

Filtros